• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Public Health . Emergence of novel SARS-CoV-2 variants keeps slowing down

tetano

Editor, Senior Moderator
BMC Public Health

. 2026 Aug 21;26(1):3402.
doi: 10.1186/s12889-026-28818-8.

Emergence of novel SARS-CoV-2 variants keeps slowing down​


Xin Sun 1 , Zhuoran Huang 2 , Jiayu Sang 1 3 , Peipei Guo 1 , Jiani Zhang 1 , Jiaxin Li 1 , Jiahui Si 4 , Wei Ma 1 , Kaida Ning 5 , Xinxue Liu 6 , George Fu Gao 7 8 9 , Jun Liu 10

Affiliations Expand


Abstract​


Background: Although COVID-19 pandemic has no longer been classified as an international public health emergency of concern after May 2023, multiple variants with different characteristics keep emerging, especially considering the recently low-level circulation of BA.3.2. Given the complex spatial-temporal characteristics of epidemics, responding to potential changes in variants is a significant public health challenge. Serotypes are defined as unique variants within specific immune response characteristics, which are used in the study of various pathogens. The sero-epidemiological features of COVID-19 may offer a new perspective for variant surveillance and public health preparedness.


Methods: Based on the global SARS-CoV-2 genome deposition data in Our World in Data (OWID) based on GISAID from March 1, 2021 to May 3, 2024, we analyzed the epidemic features of different variants based on the serotype concept and combined with cross-sectional studies.


Results: In the dataset comprising variants from 58 countries or regions with complete information, we calculated the median duration times of epidemic, the median epidemic peak times for Serotypes Ⅱ-Ⅴ and the median alternation times of epidemic for Serotypes I-Ⅱ to Ⅴ-Ⅵ respectively. An increasing trend was observed during these time period between the epidemics of Serotypes Ⅱ, Ⅲ, Ⅳ and Ⅴ, except the longer duration time for Serotype I. By constructing a regression and curve regression equation, the potential emerging of a new serotype can be explored, and a possible time window for its emergence- around 2025, or even later, which may match with the emerging of BA.3.2.


Conclusion: The gradually-increased prevalence periods for SARS-CoV-2 serotypes except Serotype I may suggest a slowing down mutation rate. Understanding the epidemic time of different serotypes can provide insight into the surveillance and forecasting of COVID-19.

Keywords: Forecast; Prevalence; SARS-CoV-2; Serotypes; Slow.
 
Back
Top Bottom